FN1 and adenocarcinoma: From preventing the migration and settlement of Fn from the oral cavity to the intestine, to regulating the imbalance of intestinal flora and inflammation caused by Fn, and then inhibiting the progression of adenomas and adenocarcinomas promoted by Fn, BBR not only coincides with the drug circulation path and bacterial migration path, but also covers multiple stages of CRC from prevention to treatment.